☆ 4.7 Letter

Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML

LEUKEMIA (2010)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 24, Issue 7, Pages 1375-1378

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2010.107

Keywords

-

Categories

Oncology Hematology

Funding

  1. NCI NIH HHS [R01 CA130876, R37 CA036167, R01 CA036167, P01 CA066996, CA36167, CA66996] Funding Source: Medline
  2. NIDDK NIH HHS [P01 DK050654, DK50654] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.